Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor

Rinat Abramovitch; Michal Neeman; Reuven Reich; Ilan Stein; Eli Keshet; Judith Abraham; Arie Solomon; Moshe Marikovsky

doi:10.1016/S0014-5793(98)00283-X

Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor

Rinat Abramovitch, Michal Neeman, Reuven Reich, Ilan Stein, Eli Keshet, Judith Abraham, Arie Solomon, Moshe Marikovsky^*

^*Corresponding author for this work

Department of Immunology and Cancer Research

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) a patent mitogen and migration factor for vascular smooth muscle cells (SMC), promoted neovascularization in vivo in the rabbit cornea. MRI demonstrated quantitatively tile angiogenic effect of HB-EGF when introduced subcutaneously into nude mice. HB-EGF is not directly mitogenic to endothelial cells but it induced the migration of bovine endothelial cells and release of endothelial cell mitogenic activity from bovine vascular SMC. This mitogenic activity was specifically blocked by neutralizing anti-vascular endothelial growth factor (VEGF) antibodies. In contrast, EGF or transforming growth factor-α. (TGF-α) had almost no effect on release of endothelial mitogenicity from SMC. In addition, RT-PCR analysis demonstrated that VEGF₁₆₅ mRNA levels mere increased in vascular SMC 4-10-fold by 0.35-2 nM of HB-EGP, respectively. Our data suggest that HB-EGF, as a mediator of intercellular communication, may play a new important role in supporting wound healing, tumor progression and atherosclerosis by stimulating angiogenesis.

Original language	American English
Pages (from-to)	441-447
Number of pages	7
Journal	FEBS Letters
Volume	425
Issue number	3
DOIs	https://doi.org/10.1016/S0014-5793(98)00283-X
State	Published - 3 Apr 1998

Bibliographical note

Funding Information:
This work was supported by a grant from the Chief Scientist of the Israel Ministry of Health (to M.M. and M.N.), by a Research Career Development Award from the Israel Cancer Research Fund (to M.N.) and by a grant from The Israel Science Foundation (to M.N.). M.N. is the incumbent of the Dr. Phil Gold Career Development Chair in Cancer Research. R.A. is a recipient of a fellowship from the Charles Clore foundation.

Keywords

Angiogenesis
Endothelial cell
Heparin-binding epidermal growth factor-like growth factor
Vascular endothelial growth factor
Vascular smooth msucle cell

Access to Document

10.1016/S0014-5793(98)00283-X

Cite this

Abramovitch, R., Neeman, M., Reich, R., Stein, I., Keshet, E., Abraham, J., Solomon, A., & Marikovsky, M. (1998). Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Letters, 425(3), 441-447. https://doi.org/10.1016/S0014-5793(98)00283-X

@article{d4c60095e8f44ac4a72cf782e0612995,

title = "Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor",

abstract = "Heparin-binding epidermal growth factor-like growth factor (HB-EGF) a patent mitogen and migration factor for vascular smooth muscle cells (SMC), promoted neovascularization in vivo in the rabbit cornea. MRI demonstrated quantitatively tile angiogenic effect of HB-EGF when introduced subcutaneously into nude mice. HB-EGF is not directly mitogenic to endothelial cells but it induced the migration of bovine endothelial cells and release of endothelial cell mitogenic activity from bovine vascular SMC. This mitogenic activity was specifically blocked by neutralizing anti-vascular endothelial growth factor (VEGF) antibodies. In contrast, EGF or transforming growth factor-α. (TGF-α) had almost no effect on release of endothelial mitogenicity from SMC. In addition, RT-PCR analysis demonstrated that VEGF165 mRNA levels mere increased in vascular SMC 4-10-fold by 0.35-2 nM of HB-EGP, respectively. Our data suggest that HB-EGF, as a mediator of intercellular communication, may play a new important role in supporting wound healing, tumor progression and atherosclerosis by stimulating angiogenesis.",

keywords = "Angiogenesis, Endothelial cell, Heparin-binding epidermal growth factor-like growth factor, Vascular endothelial growth factor, Vascular smooth msucle cell",

author = "Rinat Abramovitch and Michal Neeman and Reuven Reich and Ilan Stein and Eli Keshet and Judith Abraham and Arie Solomon and Moshe Marikovsky",

note = "Funding Information: This work was supported by a grant from the Chief Scientist of the Israel Ministry of Health (to M.M. and M.N.), by a Research Career Development Award from the Israel Cancer Research Fund (to M.N.) and by a grant from The Israel Science Foundation (to M.N.). M.N. is the incumbent of the Dr. Phil Gold Career Development Chair in Cancer Research. R.A. is a recipient of a fellowship from the Charles Clore foundation.",

year = "1998",

month = apr,

day = "3",

doi = "10.1016/S0014-5793(98)00283-X",

language = "American English",

volume = "425",

pages = "441--447",

journal = "FEBS Letters",

issn = "0014-5793",

publisher = "Wiley-Blackwell",

number = "3",

}

Abramovitch, R, Neeman, M, Reich, R, Stein, I, Keshet, E, Abraham, J, Solomon, A & Marikovsky, M 1998, 'Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor', FEBS Letters, vol. 425, no. 3, pp. 441-447. https://doi.org/10.1016/S0014-5793(98)00283-X

Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. / Abramovitch, Rinat; Neeman, Michal; Reich, Reuven et al.
In: FEBS Letters, Vol. 425, No. 3, 03.04.1998, p. 441-447.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor

AU - Abramovitch, Rinat

AU - Neeman, Michal

AU - Reich, Reuven

AU - Stein, Ilan

AU - Keshet, Eli

AU - Abraham, Judith

AU - Solomon, Arie

AU - Marikovsky, Moshe

N1 - Funding Information: This work was supported by a grant from the Chief Scientist of the Israel Ministry of Health (to M.M. and M.N.), by a Research Career Development Award from the Israel Cancer Research Fund (to M.N.) and by a grant from The Israel Science Foundation (to M.N.). M.N. is the incumbent of the Dr. Phil Gold Career Development Chair in Cancer Research. R.A. is a recipient of a fellowship from the Charles Clore foundation.

PY - 1998/4/3

Y1 - 1998/4/3

N2 - Heparin-binding epidermal growth factor-like growth factor (HB-EGF) a patent mitogen and migration factor for vascular smooth muscle cells (SMC), promoted neovascularization in vivo in the rabbit cornea. MRI demonstrated quantitatively tile angiogenic effect of HB-EGF when introduced subcutaneously into nude mice. HB-EGF is not directly mitogenic to endothelial cells but it induced the migration of bovine endothelial cells and release of endothelial cell mitogenic activity from bovine vascular SMC. This mitogenic activity was specifically blocked by neutralizing anti-vascular endothelial growth factor (VEGF) antibodies. In contrast, EGF or transforming growth factor-α. (TGF-α) had almost no effect on release of endothelial mitogenicity from SMC. In addition, RT-PCR analysis demonstrated that VEGF165 mRNA levels mere increased in vascular SMC 4-10-fold by 0.35-2 nM of HB-EGP, respectively. Our data suggest that HB-EGF, as a mediator of intercellular communication, may play a new important role in supporting wound healing, tumor progression and atherosclerosis by stimulating angiogenesis.

AB - Heparin-binding epidermal growth factor-like growth factor (HB-EGF) a patent mitogen and migration factor for vascular smooth muscle cells (SMC), promoted neovascularization in vivo in the rabbit cornea. MRI demonstrated quantitatively tile angiogenic effect of HB-EGF when introduced subcutaneously into nude mice. HB-EGF is not directly mitogenic to endothelial cells but it induced the migration of bovine endothelial cells and release of endothelial cell mitogenic activity from bovine vascular SMC. This mitogenic activity was specifically blocked by neutralizing anti-vascular endothelial growth factor (VEGF) antibodies. In contrast, EGF or transforming growth factor-α. (TGF-α) had almost no effect on release of endothelial mitogenicity from SMC. In addition, RT-PCR analysis demonstrated that VEGF165 mRNA levels mere increased in vascular SMC 4-10-fold by 0.35-2 nM of HB-EGP, respectively. Our data suggest that HB-EGF, as a mediator of intercellular communication, may play a new important role in supporting wound healing, tumor progression and atherosclerosis by stimulating angiogenesis.

KW - Angiogenesis

KW - Endothelial cell

KW - Heparin-binding epidermal growth factor-like growth factor

KW - Vascular endothelial growth factor

KW - Vascular smooth msucle cell

UR - http://www.scopus.com/inward/record.url?scp=0032478654&partnerID=8YFLogxK

U2 - 10.1016/S0014-5793(98)00283-X

DO - 10.1016/S0014-5793(98)00283-X

M3 - Article

C2 - 9563510

AN - SCOPUS:0032478654

SN - 0014-5793

VL - 425

SP - 441

EP - 447

JO - FEBS Letters

JF - FEBS Letters

IS - 3

ER -

Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this